Sun Pharmaceutical Industries Ltd.

Financial

	Sun Pharma Inds.	Cipla	Torrent Pharma
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	661.0 .	282.0 .	172.0 .
Number of ANDA's Approved By USFDA	542.0 .	217.0 .	132.0 .
Domestic Sales Growth - YoY	12.0 %	6.8 %	12.3 %
US DMF Filings	529.0 .	2472.0 .	n/a
US DMF Approval	401.0 .	n/a	n/a
R&D as a % of Total Sales	6.5 %	6.2 %	5.0 %
Financials
5 yr Average ROE	11.67 %	13.9 %	20.79 %
5yr average Equity Multiplier	1.33	1.25	2.16
5yr Average Asset Turnover Ratio	0.57	0.78	0.69
5yr Avg Net Profit Margin	15.4 %	14.31 %	13.95 %
Price to Book	5.46	4.05	16.15
P/E	38.0	23.42	61.23
5yr Avg Cash Conversion Cycle	-46.88 Days	-4.31 Days	-186.79 Days
Inventory Days	65.22 Days	57.83 Days	54.98 Days
Days Receivable	84.33 Days	50.64 Days	40.18 Days
Days Payable	175.41 Days	105.99 Days	298.32 Days
5yr Average Interest Coverage Ratio	44.12	53.73	7.38
5yr Avg ROCE	18.0 %	19.36 %	25.78 %
5yr Avg Operating Profit Margin	26.44 %	23.02 %	30.49 %
5 yr average Debt to Equity	0.06	0.03	0.66
5yr CAGR Net Profit	30.35 %	17.0 %	8.83 %
5yr Average Return on Assets	8.92 %	11.19 %	9.73 %
Shareholdings
Promoter Holding	54.48 %	29.19 %	68.31 %
Share Pledged by Promoters	0.88 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-4.42 %	-2.94 %
Change in Mutual Fund Holding (3 Yrs)	0.79 %	7.05 %	-2.83 %

Business

	Sun Pharma Inds.	Cipla	Torrent Pharma
Product Wise Break-Up	Product Wise Break-Up India Branded Generics 33.0 US Formulations 31.0 Emerging Market 18.0 Western Europe & Other Markets 13.0 Active Pharmaceutical Ingredient (API) 5.0 New ventures 0 Pharmaceuticals 0 Domestic formulations 0 Contract Manf. 0 Brazil/Latam 0 Germany/Europe 0	Product Wise Break-Up Brazil/Latam 0 India Branded Generics 0 Contract Manf. 0 Western Europe & Other Markets 0 Active Pharmaceutical Ingredient (API) 0 Emerging Market 0 Pharmaceutical 93.68 New ventures 6.32 Domestic formulations 0 Germany/Europe 0 US Formulations 0	Product Wise Break-Up Brazil 8.98 India Branded Generics 0 Contract Manufacturing 6.15 Western Europe & Other Markets 0 Active Pharmaceutical Ingredient (API) 0 Emerging Market 0 Pharmaceuticals 0 New ventures 0 Domestic Formulations 42.15 Germany 13.15 US Formulations 20.71 Others 8.86
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 20.0 Cardiac Science 17.0 Gastro Intestinal 14.0 Anti - Diabetes 8.0 Pain Management 7.0 Anti-Infective 6.0 Respiratory Systems 5.0 Vitamins / Minerals / Nutrients 5.0 Gynecology 4.0 Dermatology 4.0 Ophthalmology 3.0 Urology 3.0 Anti-infectives 0 Cardiac 0 Gastro Intestinal 0 Antivirals 0 Derma 0 Neuro /CNS 0 Gynaec. 0 Vitamins 0 Antineoplast 0 Opthal/Otologicals 0 Oncology 0 Anti Diabetic 0 Others 4.0	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 4.5 Ophthalmology 0 Cardiac Science 11.8 Gynaec. 0 Antineoplast 0 Anti-Infective 13.8 Pain Management 0 Gynecology 0 Ophthalmology 2.6 Respiratory Systems 0 Oncology 0 Anti-Infective 0 Central Nervous System (CNS) 0 Cardiac Science 0 Dermatology 0 Antivirals 0 Anti - Diabetes 5.5 Urology 5.1 Vitamins / Minerals / Nutrients 0 Gastro Intestinal 5.5 Anti - Diabetes 0 Vitamins 0 Derma 3.5 Others 47.7	-
Location Wise Break-Up	Location Wise Break-Up India 33.39 USA 32.68 Emerging Market 19.13 Rest of the World 14.8 SAGA 0 Europe 0 Global API 0 North America 0 Germany 0 Brazil 0	Location Wise Break-Up Global API 1.0 Rest of the World 0 Brazil 0 Emerging Market 0 USA 0 North America 28.0 India 44.0 Germany 0 Europe 12.0 SAGA 13.0 Others 2.0	Location Wise Break-Up Global API 0 Rest of the World 0 Brazil 6.86 Emerging Market 0 USA 9.69 North America 0 India 56.99 Germany 9.69 Europe 0 SAGA 0 Others 16.77

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

SIGN UP FOR FREE